Consumo de dexametasona en un establecimiento farmacéutico privado de Trujillo, periodo marzo- agosto 2020 y 2021.
No Thumbnail Available
Date
2022
Authors
Morales Vidal, Tania Jeraldine
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
El presente informe tiene por objetivo determinar el consumo de dexametasona y sus equivalentes comerciales como dexacler, dexalab, desazona y dexamex en tabletas orales de 4mg en un establecimiento farmacéutico privado de Trujillo, durante el periodo marzo-agosto 2020 y 2021. Para la recolección y análisis de los datos se utilizó la base de datos fx Farma versión 3.4 del establecimiento farmacéutico, las cuales se procesó en una hoja de Microsoft Excel 2016 y para la determinación de consumo el parámetro de medida DDD/1000hb/día. Obteniendo los consumos mensuales durante el periodo marzo-agosto 2021, dexacler 4mg tabletas fue mayor durante el mes de marzo con 85 unidades dispensadas y en el mes de abril fue dexametasona 4mg tabletas con 100 unidades dispensadas. Para el consumo expresado DDD/1000hb/día dispensadas mensual fue mayor para dexametasona 4mg en tabletas con 0.009 y el consumo mensual menor fue con dexalab de 4mg en tabletas con 0.0002 en el periodo de estudio marzo-agosto 2021. Finalmente se determinó consumo de dexametasona de 4 mg en tabletas y sus equivalentes comerciales dispensados durante el periodo de marzo- agosto 2020 fue mayor con un total de 2790 unidades dispensadas y durante el periodo de marzo-agosto 2021 fue un total de 667 unidades dispensadas en un establecimiento farmacéutico privado de Trujillo
ABSTRACT This report aims to determine the consumption of dexamethasone and its commercial equivalents such as dexacler, dexalab, desazona and dexamex in 4mg oral tablets in a private pharmaceutical establishment in Trujillo, during the period March-August 2020 and 2021. For the collection and analysis of the data, the fx Farma version 3.4 database of the pharmaceutical establishment was used, which was processed in a Microsoft Excel 2016 sheet and for the determination of consumption the measurement parameter DDD/1000hb/day. Obtaining the monthly consumptions during the period March-August 2021, dexacler 4mg tablets was higher during the month of March with 85 units dispensed and in the month of April it was dexamethasone 4mg tablets with 100 units dispensed. For the expressed consumption DDD/1000hb/day dispensed monthly was higher for dexamethasone 4mg in tablets with 0.009 and the lowest monthly consumption was with dexalab of 4mg in tablets with 0.0002 in the study period March-August 2021. Finally, dexamethasone consumption of 4 mg in tablets and its commercial equivalents dispensed during the period of March-August 2020 was higher with a total of 2790 units dispensed and during the period of March-August 2021 was a total of 667 units dispensed in a private pharmaceutical establishment in Trujillo.
ABSTRACT This report aims to determine the consumption of dexamethasone and its commercial equivalents such as dexacler, dexalab, desazona and dexamex in 4mg oral tablets in a private pharmaceutical establishment in Trujillo, during the period March-August 2020 and 2021. For the collection and analysis of the data, the fx Farma version 3.4 database of the pharmaceutical establishment was used, which was processed in a Microsoft Excel 2016 sheet and for the determination of consumption the measurement parameter DDD/1000hb/day. Obtaining the monthly consumptions during the period March-August 2021, dexacler 4mg tablets was higher during the month of March with 85 units dispensed and in the month of April it was dexamethasone 4mg tablets with 100 units dispensed. For the expressed consumption DDD/1000hb/day dispensed monthly was higher for dexamethasone 4mg in tablets with 0.009 and the lowest monthly consumption was with dexalab of 4mg in tablets with 0.0002 in the study period March-August 2021. Finally, dexamethasone consumption of 4 mg in tablets and its commercial equivalents dispensed during the period of March-August 2020 was higher with a total of 2790 units dispensed and during the period of March-August 2021 was a total of 667 units dispensed in a private pharmaceutical establishment in Trujillo.
Description
Keywords
Dexametasona, DDD, Consumo.